| NDC Code | 58602-128-20 |
|---|
| Package Description | 1 BOTTLE in 1 CARTON (58602-128-20) > 240 mL in 1 BOTTLE |
|---|
| Product NDC | 58602-128 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Aurophen Cold Multi-symptom Severe |
|---|
| Non-Proprietary Name | Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, And Phenylephrine Hydrochloride |
|---|
| Dosage Form | LIQUID |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20150430 |
|---|
| End Marketing Date | 20220622 |
|---|
| Marketing Category Name | OTC MONOGRAPH FINAL |
|---|
| Application Number | part341 |
|---|
| Manufacturer | Aurohealth LLC |
|---|
| Substance Name | ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
|---|
| Strength | 325; 10; 200; 5 |
|---|
| Strength Unit | mg/15mL; mg/15mL; mg/15mL; mg/15mL |
|---|
| Pharmacy Classes | Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC] |
|---|